WertQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMMittelzufluss aus Investitionstätigkeit030.98 M28.99 M0-1.34 M—Zahlungsströme aus der Finanzierungstätigkeit742 K67.43 M79.42 M17.88 M98.58 M263.31 MFreier Cashflow-25.1 M-38.68 M-32.66 M-36.22 M-29.95 M-137.51 M
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.